Regions Financial Corp’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Regions Financial Corp’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-493	Closed	-$4K	–	867
2023 Q1	$4K	Hold	493	–	–	﹤0.01%	833
2022 Q4	$6K	Hold	493	–	–	﹤0.01%	826
2022 Q3	$7K	Hold	493	–	–	﹤0.01%	816
2022 Q2	$17K	Hold	493	–	–	﹤0.01%	849
2022 Q1	$20K	Hold	493	–	–	﹤0.01%	903
2021 Q4	$21K	Hold	493	–	–	﹤0.01%	920
2021 Q3	$33K	Hold	493	–	–	﹤0.01%	885
2021 Q2	$38K	Hold	493	–	–	﹤0.01%	895
2021 Q1	$32K	Hold	493	–	–	﹤0.01%	844
2020 Q4	$17K	Sell	493 -221	-31%	-$9.83K	﹤0.01%	829
2020 Q3	$39K	Hold	714	–	–	﹤0.01%	783
2020 Q2	$27K	Hold	714	–	–	﹤0.01%	792
2020 Q1	$18K	Buy	+714	New	+$30.3K	﹤0.01%	793

Other funds holding DMK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Regions Financial Corp's DMK Position: Q2 2023 in Review

Regions Financial Corp sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2023, closing a stake of 493 shares — an estimated $4K sold.

Regions Financial Corp first reported a position in DMK in Q1 2020 and held it in 13 quarters. The position peaked at $39K in Q3 2020. 22 funds tracked by Wall St. Rank hold DMK as of Q2 2023.

Regions Financial Corp reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2023 after selling out during the quarter.
Regions Financial Corp sold 493 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2023, an estimated $4K.
Regions Financial Corp first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2020 and held it in 13 quarters.
Regions Financial Corp's DMK Pharmaceuticals Corporation Common Stock position peaked at $39K in Q3 2020.
22 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2023.

Based on Regions Financial Corp's 13F filing for Q2 2023, filed 9 Aug 2023.